Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Juliet E Compston

Showing results (11-20 of 92) with videos related to

Pageof 10
Sort By:
Lancet (London, England)|September 19, 2006
Compliance with osteoporosis therapy is the weakest linkJuliet E Compston, Ego Seeman
The Lancet. Diabetes & Endocrinology|July 25, 2024
Bone health in adults with obesity before and after interventions to promote weight lossJulien Paccou, Juliet E Compston
BMJ (Clinical Research Ed.)|May 24, 2012
Bisphosphonates in the treatment of osteoporosisKenneth E Poole, Juliet E Compston
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|January 25, 2012
Bisphosphonate therapy for osteoporosis: the long and short of itJuliet E Compston, John P Bilezikian
Clinical Endocrinology|May 29, 2002
Combination therapy for postmenopausal osteoporosisJuliet E Compston, Nelson B Watts
JBMR Plus|October 5, 2018
The Hidden Burden of Fractures in People Living With HIVMelissa O Premaor, Juliet E Compston
Annals of Clinical Biochemistry|January 9, 2014
Biochemical markers of bone turnover - uses and limitationsThinn Thinn Hlaing, Juliet E Compston
Age and Ageing|April 11, 2022
New national osteoporosis guidance-implications for geriatriciansCelia L Gregson, Juliet E Compston
BMJ (Clinical Research Ed.)|December 18, 2010
Testing for secondary causes of osteoporosisMelissa O Premaor, Juliet E Compston
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|July 23, 2020
Defining Very High Fracture Risk: Is FRAX Fit for Purpose?Juliet E Compston, Matthew T Drake
Pageof 10

Showing results (11-20 of 92) with videos related to

Sort By:
Pageof 10
Lancet (London, England)|September 19, 2006
Compliance with osteoporosis therapy is the weakest linkJuliet E Compston, Ego Seeman
The Lancet. Diabetes & Endocrinology|July 25, 2024
Bone health in adults with obesity before and after interventions to promote weight lossJulien Paccou, Juliet E Compston
BMJ (Clinical Research Ed.)|May 24, 2012
Bisphosphonates in the treatment of osteoporosisKenneth E Poole, Juliet E Compston
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|January 25, 2012
Bisphosphonate therapy for osteoporosis: the long and short of itJuliet E Compston, John P Bilezikian
Clinical Endocrinology|May 29, 2002
Combination therapy for postmenopausal osteoporosisJuliet E Compston, Nelson B Watts
JBMR Plus|October 5, 2018
The Hidden Burden of Fractures in People Living With HIVMelissa O Premaor, Juliet E Compston
Annals of Clinical Biochemistry|January 9, 2014
Biochemical markers of bone turnover - uses and limitationsThinn Thinn Hlaing, Juliet E Compston
Age and Ageing|April 11, 2022
New national osteoporosis guidance-implications for geriatriciansCelia L Gregson, Juliet E Compston
BMJ (Clinical Research Ed.)|December 18, 2010
Testing for secondary causes of osteoporosisMelissa O Premaor, Juliet E Compston
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|July 23, 2020
Defining Very High Fracture Risk: Is FRAX Fit for Purpose?Juliet E Compston, Matthew T Drake
Pageof 10